tradingkey.logo
tradingkey.logo
検索

Bioventus Inc

BVS
ウォッチリストに追加
10.480USD
+0.630+6.40%
終値 07/02, 13:00ET15分遅れの株価
703.18M時価総額
24.52直近12ヶ月PER

詳細情報 Bioventus Inc 企業名

Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.

Bioventus Incの企業情報

企業コードBVS
会社名Bioventus Inc
上場日Feb 11, 2021
最高経営責任者「CEO」Claypoole (Robert E)
従業員数930
証券種類Ordinary Share
決算期末Feb 11
本社所在地4721 Emperor Boulevard, Suite 100
都市DURHAM
証券取引所NASDAQ OMX - NASDAQ BASIC
United States of America
郵便番号27703
電話番号19194746700
ウェブサイトhttps://www.bioventus.com/
企業コードBVS
上場日Feb 11, 2021
最高経営責任者「CEO」Claypoole (Robert E)

Bioventus Incの経営陣

会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
138.24K
+23.35%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
117.52K
+27.47%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
111.90K
+28.85%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
108.72K
+29.69%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
32.28K
--
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
--
--
Ms. Katrina Church, J.D.
Ms. Katrina Church, J.D.
Senior Vice President, Chief Compliance Officer
Senior Vice President, Chief Compliance Officer
--
--
Mr. William A. (Bill) Hawkins, III
Mr. William A. (Bill) Hawkins, III
Non-Executive Independent Chairman of the Board
Non-Executive Independent Chairman of the Board
--
--
Mr. Guy Paul Nohra
Mr. Guy Paul Nohra
Independent Director
Independent Director
--
--
Marty Sutter ,
Marty Sutter ,
Independent Director
Independent Director
--
--
詳細を見る
会社名
会社名/ポジション
ポジション
株式保有
変動額
Ms. Susan M. Stalnecker
Ms. Susan M. Stalnecker
Independent Director
Independent Director
138.24K
+23.35%
Mr. Guido J. Neels
Mr. Guido J. Neels
Independent Director
Independent Director
117.52K
+27.47%
Mr. John A. Bartholdson
Mr. John A. Bartholdson
Independent Director
Independent Director
111.90K
+28.85%
Mr. Patrick J. (Pat) Beyer
Mr. Patrick J. (Pat) Beyer
Independent Director
Independent Director
108.72K
+29.69%
Mr. Philip G. Cowdy
Mr. Philip G. Cowdy
Independent Director
Independent Director
32.28K
--
Mr. Anthony D'adamio, J.D.
Mr. Anthony D'adamio, J.D.
Senior Vice President, General Counsel
Senior Vice President, General Counsel
--
--

よくある質問

Bioventus Incの上位5名の株主は誰ですか?

Bioventus Incの上位5名の株主は以下のとおりです。Ms. Susan M. Stalnecker

Bioventus Inc(BVS)の株式を保有している機関の数はいくつですか?

2026Q1時点で、Bioventus Incの株式を保有している機関は339社あり、保有株式の総市場価値は約52.51Mで、全体の77.51%を占めています。2025Q4と比較して、機関の持ち株は-10203484.00増加しています。

Bioventus Incの最大の収益源は何ですか?

2026Q1において、Pain Treatments部門がBioventus Incにとって最大の収益を生み出しており、その金額は279.06Mで、全収益の49.12%を占めています。